Abstract: . . .  Lock JE, Wessel DL. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. J Am Coll Cardiol. 1999;33:813-819. 14. Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease . Vasodilator capacity and cellular mechanisms. Circulation 2001; 103: 544-548 15. Costard-Jackle A, Fowler . . .
. . .  on operative results in children with ventricular septal defect. Pediatr Cardiol. 1982;3:41-46. 10. Houde C, Bohn DJ, Freedom RM, Rabinovitch M. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. Br Heart J. 1993;70:461-468. 11. Winberg P, Lundell BPW, Gustafsson LE. Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease . Br Heart J. 1994;71:282-286. 12. . . .
. . .  testing. J Am Coll Cardiol. 1999;33:813-819. 14. Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease . Vasodilator capacity and cellular mechanisms. Circulation 2001; 103: 544-548 15. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing . . .
. . .  hypertension in children with congenital heart disease . Vasodilator capacity and cellular mechanisms. Circulation 2001; 103: 544-548 15. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprussiate is useful in defining a high risk group. Am J Coll Cardiol. 1992;19:48-54. 16. Heath D, Edwards JE: The pathology of hypertensive . . .
. . .  transplantation: testing of potential reversibility of pulmonary hypertension with nitroprussiate is useful in defining a high risk group. Am J Coll Cardiol. 1992;19:48-54. 16. Heath D, Edwards JE: The pathology of hypertensive pulmonary vascular disease . Circulation 1958; 28: 533-47 Top Page 6 Your questions, contributions and commentaries will be answered by the lecturer or experts on the subject in the Pediatric Cardiology list. . . .
. . .  E-Mail address: @ Send Erase 2nd Virtual Congress of Cardiology Dr. Florencio Garfalo Steering Committee President Dr. Ral Bretal Scientific Committee President Dr. Armando Pacher Technical Committee - CETIFAC President fgaro@fac.org.ar fgaro@satlink.com rbretal@fac.org.ar rbretal@netverk.com.ar apacher@fac.org.ar apacher@satlink.com Copyright 1999-2001 . . .
--3000,6,250,3448,15652